Works matching IS 11753277 AND DT 2018 AND VI 18 AND IP 1


Results: 8
    1
    2
    3

    Targeting the Prostacyclin Pathway with Selexipag in Patients with Pulmonary Arterial Hypertension Receiving Double Combination Therapy: Insights from the Randomized Controlled GRIPHON Study.

    Published in:
    American Journal of Cardiovascular Drugs, 2018, v. 18, n. 1, p. 37, doi. 10.1007/s40256-017-0262-z
    By:
    • Coghlan, J.;
    • Channick, Richard;
    • Chin, Kelly;
    • Scala, Lilla;
    • Galiè, Nazzareno;
    • Ghofrani, Hossein-Ardeschir;
    • Hoeper, Marius;
    • Lang, Irene;
    • McLaughlin, Vallerie;
    • Preiss, Ralph;
    • Rubin, Lewis;
    • Simonneau, Gérald;
    • Sitbon, Olivier;
    • Tapson, Victor;
    • Gaine, Sean
    Publication type:
    Article
    4
    5
    6
    7
    8